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Abstract
Pasteurella multocida can cause a variety of diseases in various species of mammals and birds throughout the world but
nothing is known about its importance for wild great apes. In this study we isolated P. multocida from wild living,
habituated chimpanzees from Taı ¨ National Park, Co ˆte d’Ivoire. Isolates originated from two chimpanzees that died during a
respiratory disease outbreak in 2004 as well as from one individual that developed chronic air-sacculitis following this
outbreak. Four isolates were subjected to a full phenotypic and molecular characterisation. Two different clones were
identified using pulsed field gel electrophoresis. Multi Locus Sequence Typing (MLST) enabled the identification of previous
unknown alleles and two new sequence types, ST68 and ST69, were assigned. Phylogenetic analysis of the superoxide
dismutase (sodA) gene and concatenated sequences from seven MLST-housekeeping genes showed close clustering within
known P. multocida isolated from various hosts and geographic locations. Due to the clinical relevance of the strains
described here, these results make an important contribution to our knowledge of pathogens involved in lethal disease
outbreaks among endangered great apes.
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Introduction
Pasteurella multocida is a gram negative coccobacillus which
colonizes the nasopharynx of many wild and domestic animals. It
has a wide disease and host spectrum, ranging from clinical
conditions where it is considered a primary pathogen, such as
hemorrhagic septicaemia in cattle and fowl cholera in birds,
through to conditions where it can behave as a secondary invader,
for example in cases with pneumonic lesions [1,2].
Research on P. multocida has to date primarily focussed on
strains from livestock, poultry or companion animals. In humans,
however, there are few data on P. multocida which is typically
absent from the normal human bacterial flora. When human
infections do occur they are predominantly as a result of bites or
scratches by dogs and cats [3–6]. P. multocida may also cause upper
respiratory tract infections, including sinusitis, epiglottitis and
pharyngitis [3,6]. In rare cases, lower respiratory tract infections,
such as pneumonia and tracheobronchitis can develop, usually in
individuals with underlying pulmonary disease [7–9]. P. multocida is
also an infrequent cause of systemic infections such as meningitis
and septicaemia, especially in the very young, the elderly and the
immunocomprised [6,10].
In nonhuman primates (NHP), respiratory tract infections due
to P. multocida have been described for various species held in
captivity [11–13]. For example, analysing respiratory tract disease
among a dynamic laboratory colony including .8000 animals and
10 different species of NHPs, P. multocida was among the major
bacterial pathogens isolated [11]. Together with Streptococcus
pneumoniae, P. multocida was the most common bacterial isolate
from the respiratory tract of nearly 2500 macaques (Macaca
fascicularis and M. mulatta) that died from pneumonia [14], and in
the South American owl monkey (A. trivirgatus) P. multocida was
found as the principle respiratory pathogen responsible for disease
[11]. P. multocida has also been associated with air-sacculitis, a
clinical condition that can be characterised by the continuous
accumulation of mucoserous or purulent fluid into the laryngeal
air sacs which has been reported in several captive primate species,
including great apes [15–18]. Apart from respiratory tract disease,
P. multocida has been reported to be associated with septicaemia in
Cebus monkeys (Cebus albifrons), septicaemia and meningitis in
squirrel monkeys (Sarmiri sciureus) and several systemic suppurative
diseases in owl monkeys (Aotus trivergatus) [19–22].
Whether pasteurellosis in NHPs arises from commensal bacteria
or from bacteria transmitted from other animals has been barely
investigated. There is only one study where P. multocida was part of
the pharyngeal flora in healthy wild-born baboons [23]. So far, no
data exist about pasteurellosis in wild NHPs.
The present study reports on the isolation of P. multocida from
wild, human-habituated, chimpanzees (Pan troglodytes verus) living in
the Taı ¨ National Park, Cote d’Ivoire. Isolates were obtained from
victims of an outbreak of respiratory disease caused by human
metapneumovirus (HMPV), Sc. pneumoniae and P. multocida [24,25]
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investigate P. multocida from wild living chimpanzees in more
detail, the obtained isolates were subjected to a broad phenotypic
and molecular characterisation.
Results
Isolation of P. multocida was achieved for three different
individuals (see table 1): three isolates originated from two females
that died in the respiratory outbreak in 2004 (IMT18907,
IMT18908, both from ‘‘Virunga’’, and IMT18909, from ‘‘Ophe-
lia’’). Samples from the third victim of the 2004 outbreak were not
cultivatable but had been identified as P. multocida-positive by PCR
previously [24]. Another isolate was obtained from a chimpanzee
called ‘‘Sagu’’ who was immobilised in 2009 (IMT18890). All
isolates were confirmed as P. multocida by PCR amplification of the
species specific gene fragment kmt1 [26].
Phenotypic characterisation
Biochemistry. All isolates fulfilled the basic biochemical
characteristics of P. multocida: they were positive for oxidase,
catalase, indole and ornithine decarboxylase and showed no
urease activity. Isolates were further characterised by fermentation
reactions of different carbohydrates (table 2). The isolates
IMT18907 and IMT18890 differed from the isolates IMT18908
and IMT18909 in the ability to ferment D-xylose. Fermentation
reactions were also considered for the typing of the subspecies;
here, variations in D-sorbitol, dulcitol and L-arabinose have been
reported to be of taxonomic relevance [27]. However, due to
conflicting fermentation patterns it was not possible to assign the
subspecies: all isolates were dulcitol-negative and D-sorbitol-
positive (characteristic for the subspecies P. multocida ssp.
multocida) but positive for the fermentation of L-arabinose
(characteristic for P. multocida ssp. gallicida).
Antimicrobial susceptibility testing. To predict the
response to antimicrobial therapy and to get hints for
anthropogenic influence, the isolates were tested against 16
antimicrobials by agar diffusion tests. The tested panel included
b-lactam antimicrobials, aminoglycosides, fluoroquinolones,
tetracyclines, sulfadimidine, lincosamide, polymyxine and
chloramphenicole. Only minor differences between isolates were
observed and resistance was generally low: all isolates were
resistant to clindamycin and intermediate susceptible to
tetracycline. Isolate IMT18890 was additionally resistant to
sulfamethoxazole/trimethoprim (table 3).
Molecular characterisation
Macrorestriction analysis and pulsed-field gel electro-
phoresis. To differentiate the P. multocida isolates macrore-
striction and subsequent pulsed-field gel electrophoresis (PFGE)
was performed: Using SmaI, two patterns were distinguished,
differentiating between the isolates IMT18907 and IMT18890
(referred to as clone 1), and between IMT18908 and IMT18909
(referred to as clone 2) (figure 1). Restriction with ApaI worked only
for isolates IMT18907 and IMT18890 and showed unique band
patterns which confirmed their clonal nature (data not shown),
whereas the isolates representing clone 2 could not be digested
with that enzyme repeatedly.
Capsular type and virulence-associated gene profile. For
further characterisation, the presence of three capsule biosynthesis
genes and 13 virulence-associated genes (VAGs) was examined by
PCR. All isolates were of capsular type A. The VAG pattern is
shown in table 4 and differed between isolates IMT18907/
IMT18890 and IMT18908/IMT18909, which is in agreement
with pheno- and genotypic differences described above. Most of the
regularly distributed VAGs could also be detected in the
chimpanzee isolates: genes coding for outer membrane proteins
(ompH and oma87), type 4 fimbriae (ptfA), superoxide dismutases
(sodA, sodC), and iron acquisition related factors (exbB/tonB) were
present in all tested isolates. Isolates were also positive for the hgbB
gene which is coding for a hemoglobin binding protein and for nanB
as a colonization-related gene. Differences were observed in the
presence of hgbA, a further hemoglobin binding protein which was
Table 1. Origins and characteristics of Pasteurella multocida isolated in this study.
P. multocida isolate Individual Clinic/ pathology
Sample
material Sampling date PFGE pattern ST Further pathogens identified
IMT18907 Virunga Pneumonia Lung tissue March 2004 1 68 Sc. pneumoniae
a; HMPV
a
IMT18908 Virunga Pneumonia Lung tissue March 2004 2 69 Sc. pneumoniae
a; HMPV
a
IMT18909 Ophelia Pneumonia Lung tissue March 2004 2 69 Sc. pneumoniae
a; HMPV
a
IMT18890 Sagu Air-sacculitis Pus May 2009 1 68 Enterobacter sp.
a,b; Prevotella sp.
b
aIdentified by PCR [24,25].
bIdentified by cultivation and subsequent phenotypical characterization.
HMPV = Human Metapneumovirus
doi:10.1371/journal.pone.0024236.t001
Table 2. Biochemical profiles of P. multocida isolates from
chimpanzees.
IMT 18907+18890 IMT 18908+18909
Oxidase ++
Catalase ++
Ornithine carboxylase ++
Indole ++
Urease 22
Trehalose +/2 +/2
Maltose 22
Saccharose ++
D-Xylose 2 +
L-Arabinose ++
D-Mannitol ++
D-Sorbitol ++
Dulcitol 22
+: positive; 2: negative; +/2: ambiguous result.
doi:10.1371/journal.pone.0024236.t002
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gene nanH, which was merely present in IMT18908/IMT18909.
PfhaB, which encodes an adhesion-related factor called Pasteurella
filamentous hemagglutinin, was only observed in isolates
IMT18907/18890. None of the isolates harboured the genes
coding for a dermonecrotoxin (toxA) and a transferrin binding
protein (tbpA), respectively.
Phylogenetic analysis of the sodA gene. To determine the
subspecies, a phylogenetic tree for the sodA gene was constructed
(figure 2). The topology of the sodA tree shows that different P.
multocida reference strains are grouping together according to their
subspecies delineation; however, statistical support was only given
for the branching of P. multocida ssp. septica on the one hand and P.
multocida ssp. multocida and ssp. gallicida on the other hand. The
chimpanzee isolates group closest with strains of the subspecies P.
multocida ssp. multocida and, in the case of IMT18907/IMT18890,
sodA sequences were even identical with strains that had been
classified as subspecies multocida (strain CNP 927 and CNP 954
[28]).
Multi Locus Sequence Typing (MLST). According to
MLST analysis [29] we found four new allele types in est, gdh,
mdh and pgi loci in both chimpanzee isolates belonging to clone 1
and also four new allele types in est, pgi, pmi and zwf loci in clone
2 (table 5). Only one allele, adk, was identical among all four
isolates. Based on this allelic profile, two new sequence types (STs)
were assigned: ST68 and ST69. To further analyse the genetic
relationship between the chimpanzee isolates, concatenated gene
sequences from both STs were compared to the available P.
Table 3. Antibiogram of P. multocida isolates (according to the standards given by CLSI [56]).
IMT 18907 IMT 18890 IMT 18908 IMT 18909
ß-lactamases
Amoxicillin-clavulanic acid S S S S
Ampicillin S S S S
Penicillin S S S S
Cefalexin S S S S
Cefazolin S S S S
Cefovecin S S S S
Aminoglycosides
Amikacin S S S S
Gentamycin S S S S
Fluoroquinolones
Enrofloxacin S S S S
Marbofloxacin S S S S
Tetracyclines
Doxycycline S S S S
Tetracycline I I I I
Sulfadimidine
Sulfamethoxazole/trimethoprim S R S S
Lincosamide
Clindamycin R R R R
Polymyxine
Polymyxin B S S S S
Chloramphenicole SSSS
S: susceptible; R: resistant; I: intermediate.
doi:10.1371/journal.pone.0024236.t003
Figure 1. Dendrogram showing macrorestriction patterns of P. multocida isolates after digestion with SmaI. Cluster analysis of Dice
similarity indices (UPGMA) was exerted to generate a dendrogram depicting the relationships among PFGE profiles using the BioNumerics software
(optimisation 0.5%, position tolerance 1.0%). P. multocida reference strain ATCC 43137 served as methodological control.
doi:10.1371/journal.pone.0024236.g001
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pmultocida/). Based on the assumption that there is no major
impact of recombination among the housekeeping loci of the
scheme used here [29], a maximum likelihood radial tree was
constructed (figure 3) using the concatenated sequences of 73 STs
which were colour-coded according to the host they had been
isolated from. Based on the tree topology, two main groups can be
distinguished: one group consists of isolates originating from birds,
humans and cats and includes a type strain of the subspecies
P. multocida ssp. septica (CIPA125). The other group (shown
partly as a subtree in figure 3A) includes strains from various hosts
(mainly birds, cattle, and pigs) and includes type strains of the
subspecies P. multocida ssp. multocida (NCTC10322) and P.
multocida ssp. gallicida (NCTC10204). The STs found in the
chimpanzees group together with strains of the latter group.
Discussion
This is the first description of P. multocida isolated from wild
great apes. Three isolates found in the lungs of the deceased
chimpanzees were compared to an isolate found in the pus from a
chimpanzee that underwent surgery due to air-sacculitis. Pheno-
typically, all isolates matched the properties of previously
described strains of the species P. multocida. PCR analysis showed
that all isolates were of capsular type A. The capsular type in P.
multocida is assumed to play a likely role in host, and to a greater
extent, in disease specificity. Capsular type A strains are
predominantly associated with fowl cholera and upper and lower
respiratory tract diseases in ruminants, pigs and rabbits [30–32].
There is scarce information on the capsule type of P. multocida
isolated from non-human primates but for humans it has been
shown that their distribution differs according to the site of
infection and that capsular type A strains are often associated with
respiratory tract infections [33,34]. This corresponds well with the
clinical picture we observed in the deceased chimpanzees.
P. multocida constitutes a heterogeneous species and virulence
features are divergent. However, efforts have been made to
correlate several virulence gene patterns to distinct hosts (i.e. cattle
and swine) and specific diseases [31,35]. The chimpanzee isolates
showed virulence gene patterns that have already been observed
among isolates linked with respiratory diseases in other hosts.
While the absence of dermonecrotoxin gene toxA (as an essential
factor in the pathogenesis of atrophic rhinitis in swine) and of the
transferrin binding protein gene tbpA (which so far has been almost
exclusively associated with ruminant P. multocida isolates) was not
unexpected, the presence of the remaining VAGs in the wild
chimpanzee isolates is comparable to that observed among
respiratory tract isolates from domestic animals. Consistent with
that, the Pasteurella filamentous hemagglutinin gene pfhaB, which
was found to be irregularly distributed among animal isolates in
previous studies [31,35], was only detected in one of the
chimpanzee clones. Initial epidemiological data on porcine strains
[35] hint towards an association of this putative adhesin with the
virulence capacity of the strains.
To determine the subspecies of the isolates, we took into
account the results from the phylogenetic analysis of the sodA gene
as well as from the fermentation reactions. However, none of these
methods allowed an unambiguous identification of the chimpan-
zee’s strains: the sodA sequences grouped firmly within strains
belonging to both the subspecies multocida and gallicida, and the
conflicting results of the biochemical characterization, including
dulcitol-negative, sorbitol-positive (as seen in ssp. multocida [27]),
Table 4. Virulence-associated gene profiles of P. multocida isolates from chimpanzees.
Virulence-associated factor Gene(s) IMT 18907+18890 IMT 18908+18909
Capsule
Capsular type A hyaD/C ++
Capsular type D dcbF 22
Capsular type F fcbD 22
Dermonecrotic toxin toxA 22
Iron acquisition factors
Transferrin binding protein tbpA 22
ExbB-ExbD-TonB-Locus exbB/tonB ++
Hemoglobin binding proteins hgbA 2 +
hgbB ++
Enzymes
Neuraminidase nanB ++
nanH 2 +
Superoxid dismutases sodC ++
sodA ++
Outer membrane proteins
Oma87 oma87 ++
OmpH ompH ++
Adhesion related genes
Filamentous hemagglutinin pfhA + 2
Type 4 fimbriae ptfA ++
+: positive; 2: negative.
doi:10.1371/journal.pone.0024236.t004
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did not allow for the identification of the subspecies either.
However, conflicting results from both molecular and phenotypic
data have been described before [38–40], which shows that the
precise typing of the subspecies is complex and has not been fully
clarified yet.
MLST is a highly specific, sensitive and stable tool and is
currently one of the ’’gold standards’’ used for typing of bacteria.
The MLST scheme used here has only recently been developed
[29] and at the time of writing consisted of 177 isolates
representing 73 STs which built six clonal complexes (with a
clonal complex being defined as STs that shared 6 or more loci).
Our analysis revealed that each clone represented four new alleles
and based on the allelic profiles two new STs were assigned (ST68
and ST69), which did not belong to any ST complex. To further
analyse the genetic relationships, concatenated gene sequences
from the chimpanzees STs were compared to all further STs from
the MLST database (http://pubmlst.org/pmultocida/). Both STs
group within strains originating from various hosts, related more
closely to the reference strains of the subspecies P. multocida ssp.
multocida and ssp. gallicida. However, it should be noted that this
database is still a work in progress. So far it consists mostly of
isolates obtained from domesticated animals (mainly of avian
origin) and from a limited number of geographical locations.
Based on the present data, it can be stated that although the
chimpanzees strains show phylogenetic differences they are still
embedded in the global epidemiology of P. multocida but further
conclusions about host- or geographic associations must not be
drawn until additional data from African countries as well as from
primates have been included in the MLST database.
The results from the antibiotic susceptibility testing can be
basically rated as positive, since isolates were only resistant to
clindamycin. This resistance is observed frequently [41] and is
most likely indigenous in P. multocida. Interestingly, isolate
IMT18890 (clone 1), which was isolated from the air sacs of the
immobilised chimpanzee in 2009, showed additional resistance to
sulfamethoxazole/trimetho prim, a drug never used in chimpan-
zees of the study groups. Since the corresponding isolate from
2004 (IMT18907; clone 1) was susceptible to that agent, the
resistance has been probably acquired by external sources. The
origin of this resistance is difficult to determine. However, since the
sulphonamide- and the trimethoprim resistance gene can be
encoded on a plasmid [42,43], it is possible that it has spread into
the forest through various interspecies transmission events. For E.
coli, such a spread of resistance genes has already been described in
chimpanzees and gorillas in Uganda [44,45] and with regard to
the previously suggested transmission of P. multocida between cattle,
pigs, and poultry (figure 3;[46]), the concurrent dissemination of
resistance determinants might appear in wildlife as well. In most
animals, infections with P. multocida are primarily transmitted by
the respiratory route via direct contact to infectious secretions,
inhalation of aerosols or by uptake of contaminated water or food
[47,48]. The Taı ¨ chimpanzees share their habitat and food
sources, such as fruit trees, with a number of different mammals
and bird species, including ruminants, rodents and also carnivores,
most of them known as carriers of P. multocida, which may
represent a source of infection for the chimpanzees.
Pasteurellosis in captive NHPs often occurs when local and
systemic defense mechanisms are impaired. Predisposing factors
include stress induced by transportation, crowding or by the
Figure 2. Phylogenetic analysis of the sodA gene. The tree was built using the maximum-likelihood method from an analysis of sodA sequences
(452 bp) from the chimpanzee’s isolates and sequences obtained from GenBank. Isolates belonging to the species P. multocida are boxed grey; the
chimpanzees isolates are written in bold. Taxon labels indicate species and strain number, including strains with identical sodA sequences (species
and subspecies assignments are according to Gautier et al. (2005) [28]). P. langaensis and P. bettyae were used as outgroup. Bootstrap values were
calculated with 500 replicates and are given in percent.
doi:10.1371/journal.pone.0024236.g002
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NHPs have developed P. multocida infections secondary to surgical
procedures or chronic catheterization [23]. The respiratory
outbreak among the chimpanzees studied here was caused by a
multifactorial infection, where HMPV as well as Sc. pneumoniae and
P. multocida were found in the lung tissue. It is difficult, therefore, to
determine the actual role of P. multocida in the causation of disease.
However, it is possible that the underlying viral infection paved the
way for the secondary bacterial infection, which ultimately could
have caused the lethal outcome.
The P. multocida isolate recovered from the purulent discharge of
the air sac of a male animal of the same community in 2009
matched with one of the strains involved in the respiratory
outbreak of 2004 (IMT18907/18890; clone 1; ST68). This, in
Figure 3. Radial Maximum Likelihood trees constructed with concatenated housekeeping gene allele sequences used for MLST
analysis. Shown left is the complete MLST tree constructed with 73 sequence types (STs) and the position of the type strains for the P. multocida
subspecies (P. multocida ssp. septica: CIPA125; P. multocida ssp. multocida: NCTC10322; P. multocida ssp. gallicida: NCTC10204). The position of the
chimpanzee isolates (boxed grey) is displayed in the subtree (A). STs are labelled with coloured dots indicating the isolation sources and ST numbers.
Bold branches indicate for bootstrap values .70%.
doi:10.1371/journal.pone.0024236.g003
Table 5. Allelic profile of P. multocida isolates according to
MLST analyses (as defined by the scheme published by
Subaaharan et al. (2010) [29]).
Isolate Allel number for gene fragment* ST
adk est gdh mdh pgi pmi zwf
IMT18907 21 33 20 17 42 26 4 68
IMT18890 21 33 20 17 42 26 4 68
IMT18908 21 40 11 14 41 34 31 69
IMT18909 21 40 11 14 41 34 31 69
*Allele numbers written in bold assign for new alleles.
doi:10.1371/journal.pone.0024236.t005
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2004), suggests that the chronic air-sacculitis had resulted from the
former respiratory disease. Similar data have been shown in
studies on air-sacculitis in orang-utans and chimpanzees respec-
tively, where several affected animals had a history of recent acute
upper respiratory tract infection [15,18]. Apart from P. multocida
we also isolated Enterobacter sp. and Prevotella sp. from the air sacs,
suggesting that P. multocida was not the single cause. This is in
agreement with the literature, where air-sacculitis has been
associated with mixed infections of enteric organisms [50].
The strains of P. multocida isolated from the Taı ¨ chimpanzees
reported here were involved in acute and/or chronic respiratory
disease. Since all the reported cases were caused by a mix of viral
and/or bacterial pathogens, it seems probable that P. multocida
might have acted as secondary pathogen. However, the question if
the chimpanzees are frequent carriers of P. multocida, or if they are
exposed to a permanent transmission risk by external sources
cannot be answered here, since an evaluation of the carrier state
would require a systematic and invasive sample collection
(including swab samples) from healthy chimpanzees, which is not
feasible without disturbing their natural behaviour.
To summarize, this is the first description of P. multocida involved
in diseases of wild living chimpanzees. To date, there is only few
detailed molecular data on strains from Africa and no data on wild
NHP-associated strains, hence it was interesting that the strains
analysed here were found to be similar to known strains of P.
multocida. Both clones were found in the lungs of chimpanzees that
died in the course of a respiratory tract disease, caused by a mix of
viral and/or bacterial pathogens. Among the Taı ¨ chimpanzees, P.
multocida was not detected in any further case of respiratory
infection before and after the cases described here [24,25].
However, acute respiratory disease is considered one of the major
threats for endangered great apes [25,51,52], therefore a profound
characterisation of the pathogens involved is of great relevance for
conservation strategies. For example, data on antimicrobial
susceptibility may help to provide adequate treatment and thus
mitigate the impact of future disease outbreaks.
Materials and Methods
Ethics statement
This research was conducted entirely on free-ranging chimpan-
zees and under permission of the wildlife authorities and research
ministries of Co ˆte d’Ivoire. Samples were collected from
chimpanzees that died of natural reason [25] and in one case
obtained from an individual on which surgery had to be
performed due to a live threatening infection. No animal was
anaesthetised or touched for the sole purpose of sample collection.
Sources of isolates
Samples were collected from wild chimpanzees from Taı ¨
National Park, Co ˆte d’Ivoire that are known individually as a
result of a project focusing on wild chimpanzee behaviour [53].
The chimpanzees are followed on a daily basis by researchers.
Whenever a chimpanzee shows signs of weakness or disease, the
individual is followed continuously and detailed data on the type
and intensity of clinical symptoms are recorded [54].
In March 2004, one community consisting of 44 chimpanzees
was hit by a respiratory disease outbreak. Morbidity and mortality
were high during this outbreak: all 28 chimpanzees observed in the
course of this outbreak were seen with symptoms of respiratory
illness and out of these eight died. Three of the eight fatalities
(‘‘Ophelia’’, ‘‘Virunga’’ and ‘‘Orest’’) were found shortly after
death and consequently necropsies were able to be performed and
tissue samples, collected therein, were stored in liquid nitrogen
[25,54]. In addition, in May 2009, a male member of the same
chimpanzee community (‘‘Sagu’’) was immobilised for the purpose
of surgically treating a case of air-sacculitis which had been
developing since 2004 (unpublished data). Swabs were taken from
the purulent discharge of the air sac and transported in charcoal
Amies Medium at +8uC (BD, Heidelberg, Germany). Samples
were exported to Germany under permission of CITES authorities
and according to national regulations.
Phenotypic characterisation
Culture conditions and biochemical analyses. Lung
tissue was placed in brain heart infusion (BHI) and incubated
overnight at 37uC before inoculation on tryptic soy yeast extract
(TSYE) agar supplemented with 5% of defibrinated sheep blood
(Oxoid, Wesel, Germany). Swab samples taken from the air-
sacculitis were inoculated on the same media directly. Isolates
were identified as P. multocida using standard biochemical
procedures, including production of catalase, oxidase, and
indole, urease activity, as well as production of ornithine
decarboxylase [55]. All isolates were further characterised by
fermentation reactions to eight carbohydrate substrates: trehalose,
maltose, saccharose, D-xylose, L-arabinose, D-mannitol, D-
sorbitol and dulcitol [55]. In case of ambiguous results, tests
were performed repeatedly.
Antimicrobial susceptibility testing. Antimicrobial susce-
ptibility was tested by agar diffusion test according to the standards
given by the Clinical and Laboratory Standards Institute [56]. The
antimicrobial agents tested included amoxicillin-clavulanic acid
(20/10 mg), amikacin (30 mg), ampicillin (10 mg), cefalexin (30 mg),
cefazolin (30 mg), cefovecin (30 mg), chloramphenicol (30 mg),
clindamycin (2 mg), doxycyclin (30 mg), enrofloxacin (5 mg),
gentamycin (10 mg), marbofloxacin (5 mg), penicillin (10 IU),
polymyxin B (300 IU), sulfamethoxazole/trimethoprim (23,75/
1,25 mg), and tetracycline (30 mg) (Becton Dickinson, Heidelberg,
Germany). Escherichia coli ATCC 25922 served as the reference
strain.
Molecular characterisation
Macrorestriction analysis and PFGE. Isolates of P.
multocida were grown overnight in BHI at 37uC and adjusted
with PBS to an optical density (OD)600 of approximately 0.7. P.
multocida ATCC 43137 (capsular type A) served as
methodological control strain. One-and-a-half millilitres of
culture was used for DNA preparation and centrifuged to obtain
a bacterial pellet (8000 rpm for 5 min). The supernatant was
discarded and the pellet re-suspended in 250 ml of PBS by
vortexing. The bacterial suspension was warmed to 37uC. The
1.2% PFGE agarose (Peqlab Biotechnologie GmbH, Erlangen,
Germany) was melted and equilibrated to 60uC. Two-hundred
and fifty microlitres of agarose were added to the bacterial
suspension and mixed thoroughly. The mixture was transferred to
plug moulds (Bio-Rad Laboratories, Munich, Germany) and the
agarose was allowed to solidify at 4uC for 20 min. Solidified plugs
were incubated in 0.5 ml of EDTA-sarcosine buffer containing
0.45 mg proteinase K (Carl Roth GmbH & Co. KG, Karlsruhe,
Germany) at 56uC overnight. Plugs were washed four times in
13 ml TE buffer for 30 minutes each at 4uC with gentle agitation.
The plugs were halved and stored in 1 ml of fresh TE buffer. Prior
to restriction, each plug was incubated with 0.2 ml 1 x restriction
buffer for 30uC at room temperature for equilibration. One half of
the plug was digested with ApaI restriction enzyme, the other with
SmaI restriction enzyme (Fermentas GmbH, St. Leon-Rot,
Germany). For ApaI, plugs were incubated overnight in 150 ml
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enzyme at 37uC. For SmaI, plugs were incubated overnight in
200 ml of 1 x restriction buffer containing 10 units of the restriction
enzyme at 30uC. After digestion, the buffer was removed and plugs
were then equilibrated in 0.5 ml TE buffer. The fragments were
separated in a 1.2% agarose gel (Peq Lab, Erlangen; Germany) in
0.5 x TBE buffer by using a CHEF-DR III system (Bio-Rad
Laboratories, Munich, Germany). The electrophoresis conditions
for ApaI were 6 V/cm at 14uC for 22 h, ramping times were 1–
30 s. Separation of SmaI fragments was conducted at 5.6 V/cm
and pulse time was ramped from 2–5 s for 11 h and 20–40 s for
13 h. PFGE profiles were compared digitally using BioNumerics
software (Version 4.6, Applied Maths, Belgium). Cluster analysis of
Dice similarity indices based on the unweighted pair group
method with arithmetic mean (UPGMA) was exerted to generate a
dendrogram depicting the relationships among PFGE profiles.
DNA extraction. Bacterial DNA was extracted by a boiling
procedure. Colony material was suspended in 50 ml of double
distilled water, boiled for 10 minutes and centrifuged. Two
microliters of the supernatant served as a template for PCR
reactions. For the sodA PCR as well as for MLST analysis - where
amplicons needed to be sequenced - total DNA was extracted
using the Master PureTM Genomic DNA Purification Kit
(Biozym Diagnostik GmbH, Hessisch Oldendorf, Germany)
according to the manufacturer’s recommendations.
PCR analysis, purification of amplicons and sequen-
cing. All isolates were tested for the Pasteurella multocida species
specific genomic sequence kmt1 [26]. PCR assays targeting the
capsular biosynthesis genes and virulence associated genes (VAG)
were performed using oligonucleotide primers, amplification
conditions and reference strains published previously [31,35,57].
MLST analysis was performed according to a previously
published scheme [29] using standard primers and protocols
given on the mlst.net site (http://pubmlst.org/pmultocida_rirdc/
info/primers.shtml). PCR fragments of the seven housekeeping
genes adk, pgi, mdh, gdh, est, pmi, and zwf were obtained for all
isolates and sequenced subsequently. New allele numbers and
sequence types (STs) were assigned through the curator and
entered in the MLST database (http://pubmlst.org/pmultocida/).
For phylogenetic and/or MLST analysis PCR products were
purified using ExoSAP (USB Europe GmBH, Staufen, Germany).
Sequencing was performed using the ABI Big Dye Termination Kit
(Applied Biosystems, Weiterstadt, Germany) in a 377 DNA
automated sequencer (Applied Biosystems), with all PCR products
being sequenced on both strands. The sodA sequences were deposited
in GenBank under accession numbers HQ003894- HQ003897.
Phylogenetic analysis. The phylogenetic tree for sodA was
calculated with sequences collected from P. multocida strains
available at the public GenBank database (http://www.ncbi.nlm.
nih.gov/) and included all available sequences from strains that
had been previously typed to the subspecies level [28]. Alignments
were constructed using the ClustalW software program in BioEdit
software version 7.0.9 [58] and sequences were collapsed into
unique haplotypes using FaBox [59]. The final data set contained
12 taxa and 464 positions. Furthermore, phylogenetic analysis was
performed using concatenated MLST allele sequences of all
available STs from the MLST database (72 STs; 3696 positions
(http://pubmlst.org/pmultocida_rirdc/)).
To determine the appropriate nucleotide substitution model,
alignments were then exported into jModeltest v0.1.1 [60,61].
According to the Akaike information criterion (AIC), comparisons of
model likelihoods were most favourable to GTR+G( sodA), and
GTR+I+G (MLST). Phylogenetic trees were built using the PhyML
webserver (http://www.atgc-montpellier.fr/phyml/; [60–62]). Equi-
librium frequencies, topology and branch lengths were optimised, the
starting tree was determined using BioNJ and both nearest neighbour
interchange (NNI) and subtree pruning and regrafting (SPR)
algorithms of tree search were used (keeping the best outcome).
Branch robustness was assessed by performing non-parametric
bootstrapping with 500 replicates (sodA) and 100 replicates (MLST),
respectively.
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